48
Participants
Start Date
April 3, 2023
Primary Completion Date
September 13, 2023
Study Completion Date
September 13, 2023
IVT with tenecteplase or alteplase
Patients received intravenous tenecteplase 0.25mg/kg (maximum dose: 25mg), administered as a bolus over 5 to 10 seconds or intravenous alteplase 0.9 mg/kg (maximum dose: 90mg), 10% as bolus and the remainder as continuous perfusion over 1 hour.
Intervention Name : Tirofiban and IVT with tenecteplase or alteplase
IVT with tenecteplase or alteplase with continuous infusion of tirofiban 0.4µg/kg/min continued for 24 to 48 hours.
Centre Hospitalier Sud Francilien, Corbeil-Essonnes
Centre Hospitalier Sud Francilien
OTHER